pc:bridg

BridGene Biosciences

BridGene Biosciences is a biotechnology company pioneering the discovery and development of innovative small-molecule drugs that target traditionally undruggable targets. Leveraging its proprietary IMTAC(TM) chemoproteomic platform, BridGene screens covalent small molecules against the entire proteome in live cells to identify novel binding sites and drug candidates for high-value targets.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―

Estimated Valuation―

Total Amount Raised$28M

Total Amount Raised$28M

Total Funding Rounds1

Total Funding Rounds1

Latest Funding Amount$28M

Latest Funding Amount$28M

Latest Funding RoundSeries B

Latest Funding RoundSeries B

Post-Money Valuation―

Post-Money Valuation―

Funding Round

Oct 16, 2025

Series B

$28.00M

―

Investors

Series B

Bayland Capital

Series B

Proxima Ventures

Series B

GTJA Investment Group

Series B

Grains Valley Venture Capital

Series B

Related News and Analysis

BridGene Biosciences Secures $28 Million Series B+ to Advance TEAD Inhibitor and Expand IMTAC Platform

BridGene Biosciences Secures $28 Million Series B+ to Advance TEAD Inhibitor and Expand IMTAC Platform

New updates have been reported about BridGene Biosciences. BridGene Biosciences has raised $28 million in a Series B+...

2M ago

BridGene Biosciences Adds Nobel Laureate Bruce Beutler to Scientific Advisory Board to Steer Autoimmune and Oncology Pipeline

BridGene Biosciences Adds Nobel Laureate Bruce Beutler to Scientific Advisory Board to Steer Autoimmune and Oncology Pipeline

New updates have been reported about BridGene Biosciences. BridGene Biosciences has strengthened its scientific and strategic bench by...

3M ago

Deel Launches Global Startup Pitch Program With Multi-Stage Investment Pool

Deel Launches Global Startup Pitch Program With Multi-Stage Investment Pool

According to a recent LinkedIn post from Deel, the company is organizing “The Pitch by Deel,” a startup...

3h ago

Deel Highlights Rapid Global Growth in Cross-Border AI Trainer Hiring

Deel Highlights Rapid Global Growth in Cross-Border AI Trainer Hiring

According to a recent LinkedIn post from Deel, the company highlights rapid global growth in demand for AI...

3h ago

Talkdesk Targets Healthcare Growth Through Presence at Becker’s Annual Meeting

Talkdesk Targets Healthcare Growth Through Presence at Becker’s Annual Meeting

According to a recent LinkedIn post from Talkdesk, the company is sending a team to the Becker’s Healthcare...

3h ago

Talkdesk Deployment at Johns Hopkins Medicine Signals Healthcare Traction

Talkdesk Deployment at Johns Hopkins Medicine Signals Healthcare Traction

According to a recent LinkedIn post from Talkdesk, Johns Hopkins Medicine is now live on the company’s customer...

3h ago

Databricks Highlights Serverless, Developer-Centric App Building in New Webinar

Databricks Highlights Serverless, Developer-Centric App Building in New Webinar

According to a recent LinkedIn post from Databricks, the company is promoting a webinar focused on building and...

3h ago

Databricks Highlights Iceberg v3 Public Preview and Ongoing Open Data Architecture Efforts

Databricks Highlights Iceberg v3 Public Preview and Ongoing Open Data Architecture Efforts

According to a recent LinkedIn post from Databricks, the company is highlighting the public preview of Iceberg v3...

3h ago

Insurtech Focuses on Document Data Quality to Improve Auto Insurance Profitability

Insurtech Focuses on Document Data Quality to Improve Auto Insurance Profitability

According to a recent LinkedIn post from Upstage, the company is emphasizing that auto insurance profitability depends heavily...

3h ago

KROMATID Highlights Visibility Challenges in In Vivo Gene Therapy

KROMATID Highlights Visibility Challenges in In Vivo Gene Therapy

According to a recent LinkedIn post from KROMATID, the company is drawing attention to what it describes as...

3h ago